These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2174599)

  • 1. Protection against lethal equine herpes virus type 1 (subtype 1) infection in hamsters by immune stimulating complexes (ISCOMs) containing the major viral glycoproteins.
    Cook RF; O'Neill T; Strachan E; Sundquist B; Mumford JA
    Vaccine; 1990 Oct; 8(5):491-6. PubMed ID: 2174599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hamster model of equine herpesvirus type 1 (EHV-1) infection; passive protection by monoclonal antibodies to EHV-1 glycoproteins 13, 14 and 17/18.
    Stokes A; Allen GP; Pullen LA; Murray PK
    J Gen Virol; 1989 May; 70 ( Pt 5)():1173-83. PubMed ID: 2471805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
    Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice.
    Liu SA; Stanfield BA; Chouljenko VN; Naidu S; Langohr I; Del Piero F; Ferracone J; Roy AA; Kousoulas KG
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28404844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp13 and gp14 results in potentiated immunity.
    Guo PX; Goebel S; Perkus ME; Taylor J; Norton E; Allen G; Languet B; Desmettre P; Paoletti E
    J Virol; 1990 May; 64(5):2399-406. PubMed ID: 2157895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenicity and immunogenicity of equine herpesvirus type 1 mutants defective in either gI or gE gene in murine and hamster models.
    Tsujimura K; Yamanaka T; Kondo T; Fukushi H; Matsumura T
    J Vet Med Sci; 2006 Oct; 68(10):1029-38. PubMed ID: 17085880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with Attenuated Equine Herpesvirus 1 Strain KyA Induces Innate Immune Responses That Protect Mice from Lethal Challenge.
    Kim SK; Shakya AK; O'Callaghan DJ
    J Virol; 2016 Sep; 90(18):8090-104. PubMed ID: 27356904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
    Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responses of ponies to equid herpesvirus-1 ISCOM vaccination and challenge with virus of the homologous strain.
    Hannant D; Jessett DM; O'Neill T; Dolby CA; Cook RF; Mumford JA
    Res Vet Sci; 1993 May; 54(3):299-305. PubMed ID: 8393207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).
    Fitzpatrick DR; Studdert MJ
    Am J Vet Res; 1984 Oct; 45(10):1947-52. PubMed ID: 6208822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals.
    Guo PX; Goebel S; Davis S; Perkus ME; Languet B; Desmettre P; Allen G; Paoletti E
    J Virol; 1989 Oct; 63(10):4189-98. PubMed ID: 2550665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
    Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of a chemically inactivated, adjuvanted vaccine to control abortigenic infection of mares by equine herpesvirus I.
    Bryans JT; Allen GP
    Dev Biol Stand; 1982; 52():493-8. PubMed ID: 6299858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mutations in the US2 and glycoprotein B genes of the equine herpesvirus 1 vaccine strain RacH have no effects on its attenuation].
    Neubauer A; Meindl A; Osterrieder N
    Berl Munch Tierarztl Wochenschr; 1999 Sep; 112(9):351-4. PubMed ID: 10507185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equine herpesvirus type 1 modified live virus vaccines: quo vaditis?
    Rosas CT; Goodman LB; von Einem J; Osterrieder N
    Expert Rev Vaccines; 2006 Feb; 5(1):119-31. PubMed ID: 16451114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR-5 agonist Salmonella abortus equi flagellin FliC enhances FliC-gD-based DNA vaccination against equine herpesvirus 1 infection.
    Zhao Y; Chang J; Zhang B; Tong P; Wang C; Ran D; Su Y
    Arch Virol; 2019 May; 164(5):1371-1382. PubMed ID: 30888564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB).
    Osterrieder N; Wagner R; Brandmüller C; Schmidt P; Wolf H; Kaaden OR
    Virology; 1995 Apr; 208(2):500-10. PubMed ID: 7747423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus.
    Van de Walle GR; May MA; Peters ST; Metzger SM; Rosas CT; Osterrieder N
    Vaccine; 2010 Jan; 28(4):1048-55. PubMed ID: 19897066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 2 virus.
    Mumford JA; Bates J
    Vet Rec; 1984 Apr; 114(15):375-81. PubMed ID: 6328729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.